Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-123538

Chief Scientific Officer sold 8,000 shares at $15.64 ($125,120)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-05 Sale : show line 1 in the form 10b5-1 −8,000 $15.64 $125,120 107,942 D
Open-market sales · 8,000 sh · avg $15.64 · $125,120
Loading xslF345X05/ownership.xml…